New You can now listen to Insurance Journal articles!Technology is on everyone’s mind. Whether it’s using big data, AI or tackling the world of cybersecurity, technology tops the list of business concerns today. For the insurance industry, technology and how data is used to improve…
Source: news.google.com – Read more
FDA approves breast cancer drug
The FDA has approved Eli Lilly’s imlunestrant, an oral estrogen receptor antagonist, for the treatment of adults with estrogen receptor positive, HER2-negative, ESR1-mutated advanced or
